Pancreas transplantation for Cystic Fibrosis: A Frequently Missed Opportunity

Date
2021-09
Language
English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Abstract

Cystic fibrosis (CF) is an inherited autosomal recessive disorder. Despite optimized therapy, the majority of affected individuals ultimately die of respiratory failure. As patients with CF are living longer, extra-pulmonary manifestations may develop including pancreatic failure, which manifests as exocrine insufficiency, and CF related diabetes (CFRD). Both of these can be managed through pancreas transplantation. Pancreas transplantation is usually performed in combination with another organ, most often with a kidney transplant for end-stage diabetic nephropathy. In the CF patient population, the two settings where inclusion of a pancreas transplant should be considered would be in combination with a lung transplant for CF pulmonary disease, or in combination with a liver for CF related liver disease with cirrhosis. This report will discuss this topic in detail, including a review of the literature regarding combinations of lung/pancreas and liver/pancreas transplant.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Fridell, J. A., Bozic, M. A., Ulrich, B. J., Lutz, A. J., & Powelson, J. A. (2021). Pancreas transplantation for Cystic Fibrosis: A Frequently Missed Opportunity. Clinical Transplantation, 35(9), e14371. https://doi.org/10.1111/ctr.14371
ISSN
1399-0012
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Transplantation
Rights
Publisher Policy
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}